论文部分内容阅读
目的:探讨研究奥硝唑联合法莫替丁治疗慢性胃炎临床疗效。方法:选取2011年8月~2013年8月在我院接受治疗的慢性胃炎患者96例,对照组给予单纯法莫替丁治疗,观察组给予法莫替丁和奥硝唑联合治疗。观察两组患者在用药后临床症状的改善、不良反应和半年复发率等情况。结果:观察组患者用药后症状的改善明显好于对照组,同时观察组患者的半年复发率明显低于对照组,P<0.05;两组患者不良反应发生率均较低且无统计学差异(P>0.05)。结论:奥硝唑联合法莫替丁用药治疗慢性胃炎能达到较好的临床疗效,且无明显不良反应,有一定的临床推广意义。
Objective: To investigate the clinical efficacy of ornidazole combined with famotidine in the treatment of chronic gastritis. Methods: Ninety-six chronic gastritis patients treated in our hospital from August 2011 to August 2013 were selected. The control group was treated with famotidine alone, and the observation group was given famotidine combined with ornidazole. Two groups of patients were observed after treatment of clinical symptoms, adverse reactions and six-year recurrence rate and so on. Results: The symptom improvement in the observation group was significantly better than that in the control group. At the same time, the half-year relapse rate in the observation group was significantly lower than that in the control group (P <0.05). The incidence of adverse reactions in the two groups was lower with no statistical difference P> 0.05). CONCLUSION: Ornidazole combined with famotidine can improve the clinical curative effect of chronic gastritis and has no obvious adverse reactions, which has some clinical promotion significance.